Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  News

News :

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesBusiness LeadersFinance ProfessionalsCalendarSectors 
The feature you requested does not exist. However, we suggest the following feature:

Wockhardt : gets USFDA nod for generic cancer drug 

share with twitter share with LinkedIn share with facebook
share via e-mail
0
01/21/2019 | 05:38pm EST

NEW DELHI: Drug firm Wockhardt Monday said it has received approval from the US health regulator for generic version of Gleevec used for treatment of cancers and tumours.

Wockhardt has received approval from the United States Food & Drug Administration (USFDA) for an abbreviated new drug application (ANDA) for 100 mg and 400 mg tablets of Imatinib Mesylate, the company said in a BSE filing.

Wockhardt's Imatinib Mesylate tablets are a generic version of Gleevec, marketed in USA and other countries by Novartis.

"Wockhardt is building a portfolio of oncology products in the US and has several pending ANDA's for oncology products," Wockhardt Founder Chairman and Group CEO Habil Khorakiwala said.

Oncology and other specialty products have always been a priority area for our US business and this product will further boost this focus, he added.

Wockhardt said it will launch this product in the United States, in a short period of time.

The product is being manufactured at a contract manufacturing facility, based near Hyderabad, the company added.

Shares of Wockhardt were trading 1.74 per cent higher at Rs 498 apiece on BSE.

(c) 2019, Express Network Pvt Ltd. All rights reserved. Provided by SyndiGate Media Inc. (Syndigate.info)., source Middle East & North African Newspapers

share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
05:38pWOCKHARDT : gets USFDA nod for generic cancer drug 
AQ
05:37pIDEA CELLULAR : Vodafone-Idea seeks moratorium for spectrum dues
AQ
05:37pTATA TELESERVICES MAHARASHTRA : NCLT approves Tata Teleservices and Bharti Airtel merger
AQ
05:37pLARSEN & TOUBRO : and Toubro shares fall after Sebi denies buyback
AQ
05:37pWE BOUGHT REAL-TIME FEED FOR BETTER CUSTOMER EXPERIENCE : Reliance Securities CEO
AQ
05:37pSTERLING BIOTECH : Initiated extradition process against four Sterling Biotech promoters, ED tells court
AQ
05:37pLIC completes acquisition of 51 per cent stake in IDBI Bank
AQ
05:37pNIPPON TELEGRAPH AND TELEPHONE : Will digital transformation really become reality in 2019?
AQ
05:37pVANGUARD SHT TERM GOVT BOND ETF : Why India needs a John C Bogle
AQ
05:37pEMIRATES TELECOMMUNICATIONS GROP : China Mobile joins Etisalat's SmartHub
AQ
Latest news
Advertisement